Digital Storytelling and Breastfeeding Education
10 de agosto de 2026 actualizado por: Zübeyde Ceylan
Evaluatıon of the Effect of Breastfeedıng Educatıon Delıvered Usıng Dıgıtal Storytellıng Methods on Mothers' Breastfeedıng Success and Breastfeedıng Self-effıcacy
The aim of this study was to evaluate the effect of breastfeeding education provided using the digital storytelling method on mothers' breastfeeding self-efficacy and breastfeeding success.
The study was conducted using a quasi-experimental pretest-posttest control group design.
A total of 216 postpartum women participated in the study, including 108 women in the intervention group and 108 women in the control group.
The intervention group received breastfeeding education based on the digital storytelling method, while the control group received routine breastfeeding education provided in the hospital.
Breastfeeding self-efficacy and breastfeeding success were evaluated after the intervention.
Descripción general del estudio
Estado
Terminado
Descripción detallada
Breastfeeding is one of the most important factors affecting maternal and infant health. Educational interventions may improve breastfeeding outcomes by increasing mothers' confidence and knowledge regarding breastfeeding practices. Digital storytelling is an innovative educational approach that combines visual, audio, and narrative elements to improve learning experiences.
This study was conducted to evaluate the effectiveness of digital storytelling-based breastfeeding education on breastfeeding self-efficacy and breastfeeding success among postpartum women. The study was carried out between September 2024 and December 2025 in the postpartum unit of Etlik City Hospital. Participants were assigned to either an intervention group receiving digital storytelling-based breastfeeding education or a control group receiving standard breastfeeding education.
Data were collected using a Demographic Information Form, the Breastfeeding Self-Efficacy Scale-Short Form, and the Bristol Breastfeeding Assessment Tool. The findings of the study are expected to contribute to the development of innovative breastfeeding education strategies and support evidence-based maternal health practices.
Tipo de estudio
De observación
Inscripción (Actual)
216
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Ankara
-
Ankara, Ankara, Turquía (Türkiye), 06010
- Etlik City Hospital
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Método de muestreo
Muestra no probabilística
Población de estudio
The study population consisted of postpartum women hospitalized in the postpartum unit of Etlik City Hospital between September 2024 and December 2025.
A total of 216 postpartum women participated in the study.
Descripción
Inclusion Criteria:
- Women aged 18 years and older
- Postpartum women
- Able to communicate in Turkish
- Literate
- Healthy mother and healthy newborn
- Voluntarily agreed to participate in the study
Exclusion Criteria:
- Refusal to participate in the study
- Mothers with conditions preventing breastfeeding
- Mothers with severe maternal or neonatal complications
- Communication problems preventing participation
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Experimental Group
Participants received breastfeeding education prepared using the digital storytelling method.
Breastfeeding self-efficacy and breastfeeding success were evaluated after the intervention.
|
|
Control Group
Participants received routine breastfeeding education provided by the hospital.
Breastfeeding self-efficacy and breastfeeding success were evaluated after the intervention.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Breastfeeding Self-Efficacy
Periodo de tiempo: Within 24 hours after breastfeeding education
|
The Breastfeeding Self-Efficacy Scale is a 33-item scale originally developed by Dennis in 1999.
Subsequently, in 2003, she developed the Short Form of the Breastfeeding Self-Efficacy Scale by reducing it to 14 items.
It is a 5-point Likert-type scale.
Scores range from a minimum of 14 to a maximum of 70; higher scores indicate greater breastfeeding self-efficacy.
Dennis states that the scale is suitable for use during the postpartum period.
Aluş Tokat, Okumuş, and Dennis conducted a reliability and validity study of the Turkish version of the short-form scale; they determined it to be suitable for the Turkish culture, finding a Cronbach's alpha value of 0.86.
|
Within 24 hours after breastfeeding education
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Breastfeeding Success
Periodo de tiempo: 5 and 12 hours after breastfeeding education
|
It is a scale developed by Ingram et al. in 1998 to assess the breastfeeding process.
Its Turkish validity and reliability were established by Dolgun et al. in 2018, yielding a Cronbach's alpha value of 0.77.
The scale evaluates breastfeeding across four main categories: positioning, latching, observable sucking ability, and maternal comfort.
Each criterion is scored on a scale of 0 to 2, resulting in a total possible score of 8. Higher scores indicate greater breastfeeding success.
The BBAT is designed for use in breastfeeding support and education programs, serving as a tool for healthcare professionals and mothers to assess the breastfeeding process.
|
5 and 12 hours after breastfeeding education
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de septiembre de 2024
Finalización primaria (Actual)
30 de diciembre de 2025
Finalización del estudio (Actual)
30 de diciembre de 2025
Fechas de registro del estudio
Enviado por primera vez
13 de junio de 2026
Primero enviado que cumplió con los criterios de control de calidad
13 de junio de 2026
Publicado por primera vez (Actual)
18 de junio de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
12 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
10 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- ZC-DSB-2024-01
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .